{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:33:54Z","timestamp":1793356434363,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-18-54"],"award-info":[{"award-number":["320.6750.2024-18-54"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jchromb.2026.125303","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:47:13Z","timestamp":1789688833000},"page":"125303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A high-throughput LC-MS\/MS assay for therapeutic drug monitoring of combined immunosuppressive and antimicrobial therapy"],"prefix":"10.1016","volume":"1284","author":[{"given":"Rongkun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanghui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jchromb.2026.125303_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"5","key":"10.1016\/j.jchromb.2026.125303_bb0010","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ekir.2025.02.019","article-title":"Improved tacrolimus therapeutic drug monitoring in kidney transplantation: optimizing an old drug prescription","volume":"10","author":"Noble","year":"2025","journal-title":"Kidney Int. Rep."},{"issue":"4","key":"10.1016\/j.jchromb.2026.125303_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1515\/dmpt-2024-0043","article-title":"Optimizing tacrolimus therapeutic drug monitoring in Tunisian kidney transplant recipients: exploring the variability in bioavailability and the correlation between pharmacokinetic parameters","volume":"39","author":"Aloui","year":"2024","journal-title":"Drug Metab. Pers. Ther."},{"issue":"3","key":"10.1016\/j.jchromb.2026.125303_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/15269248221107043","article-title":"Evaluation of a standardized tacrolimus therapeutic drug monitoring protocol in stable kidney transplant recipients","volume":"32","author":"Ky","year":"2022","journal-title":"Prog. Transplant."},{"issue":"6","key":"10.1016\/j.jchromb.2026.125303_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5067","article-title":"Simultaneous analysis of drugs administered to lung-transplanted patients using liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring","volume":"35","author":"Takasaki","year":"2021","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.jchromb.2026.125303_bb0030","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.jchromb.2026.125303_bb0035","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jchromb.2026.125303_bb0040","article-title":"Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology","volume":"54\u201355","author":"Udomkarnjananun","year":"2021","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jchromb.2026.125303_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2014.05.016","article-title":"Innovative approaches to optimizing the delivery of vancomycin in individual patients","volume":"77","author":"Pai","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jchromb.2026.125303_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154828","article-title":"Determinants of beta-lactam PK\/PD target attainment in critically ill patients: a single center retrospective study","volume":"83","author":"Gand\u00e9ga","year":"2024","journal-title":"J. Crit. Care"},{"issue":"4","key":"10.1016\/j.jchromb.2026.125303_bb0055","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1060028020948174","article-title":"Effect of therapeutic drug monitoring and cytochrome P450 2C19 genotyping on clinical outcomes of Voriconazole: a systematic review","volume":"55","author":"Lee","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jchromb.2026.125303_bb0060","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"10","key":"10.1016\/j.jchromb.2026.125303_bb0065","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1373\/clinchem.2018.287052","article-title":"Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation","volume":"64","author":"Wang","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2026.125303_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-3541-4_1","article-title":"Mass spectrometry in clinical laboratory: applications in therapeutic drug monitoring and toxicology","volume":"2737","author":"Victoria Zhang","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125303_bb0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpha.2023.09.009","article-title":"Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management","volume":"14","author":"Thu","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2026.125303_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jmsacl.2022.11.001","article-title":"LC-MS\/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring","volume":"26","author":"Radovanovic","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.jchromb.2026.125303_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2019.07.026","article-title":"A high-throughput LC-MS\/MS method for the quantification of four immunosuppressants drugs in whole blood","volume":"498","author":"Gong","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2026.125303_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113578","article-title":"A homologous series of internal standards for near universal application in the discovery LC-MS\/MS bioanalytical laboratory","volume":"190","author":"Heinle","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125303_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113764","article-title":"High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry","volume":"194","author":"Tanaka","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125303_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jmsacl.2024.06.001","article-title":"Therapeutic drug monitoring of mycophenolic acid and azole antifungals on two distinct LC-MS\/MS instruments","volume":"33","author":"Wolken","year":"2024","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.jchromb.2026.125303_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2020.03.004","article-title":"After another decade: LC-MS\/MS became routine in clinical diagnostics","volume":"82","author":"Seger","year":"2020","journal-title":"Clin. Biochem."},{"issue":"5\u20136","key":"10.1016\/j.jchromb.2026.125303_bb0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/mas.21620","article-title":"Mass spectrometry-based personalized drug therapy","volume":"39","author":"Cui","year":"2020","journal-title":"Mass Spectrom. Rev."},{"issue":"2\u20133","key":"10.1016\/j.jchromb.2026.125303_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clinbiochem.2010.10.005","article-title":"Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS\/MS, HPLC-UV and immunoassay methods","volume":"44","author":"Sallustio","year":"2011","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.jchromb.2026.125303_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00365513.2022.2056858","article-title":"Challenged comparison of tacrolimus assays","volume":"82","author":"Cremers","year":"2022","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jchromb.2026.125303_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2012.12.028","article-title":"Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry","volume":"919\u2013920","author":"Jourdil","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125303_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchromb.2009.11.017","article-title":"Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC\/MS\/MS","volume":"878","author":"Alffenaar","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.jchromb.2026.125303_bb0135","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/bcp.16004","article-title":"Development of a therapeutic drug-monitoring algorithm for outpatients receiving voriconazole: a multicentre retrospective study","volume":"90","author":"Kato","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125303_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/20420986221143266","article-title":"Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS","volume":"13","author":"Chai","year":"2022","journal-title":"Ther. Adv. Drug Saf."},{"issue":"7","key":"10.1016\/j.jchromb.2026.125303_bb0145","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/1389200216666151001121004","article-title":"Linezolid induced adverse drug reactions - an update","volume":"16","author":"Kishor","year":"2015","journal-title":"Curr. Drug Metab."},{"issue":"9","key":"10.1016\/j.jchromb.2026.125303_bb0150","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1111\/bcp.15368","article-title":"Parametric population pharmacokinetics of linezolid: a systematic review","volume":"88","author":"Qin","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"36","key":"10.1016\/j.jchromb.2026.125303_bb0155","doi-asserted-by":"crossref","first-page":"13339","DOI":"10.1073\/pnas.0804276105","article-title":"The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning","volume":"105","author":"Wilson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.jchromb.2026.125303_bb0160","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00228-023-03542-z","article-title":"Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis","volume":"79","author":"Zhang","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jchromb.2026.125303_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1515\/cclm-2015-0519","article-title":"Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS\/MS method to determine ciclosporin a, everolimus, sirolimus and tacrolimus in whole blood","volume":"54","author":"Valbuena","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2026.125303_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2014.12.009","article-title":"Incidence and risk factors of linezolid-induced lactic acidosis","volume":"31","author":"Im","year":"2015","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jchromb.2026.125303_bb0175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40262-022-01125-2","article-title":"A review of population pharmacokinetic analyses of linezolid","volume":"61","author":"Band\u00edn-Vilar","year":"2022","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.jchromb.2026.125303_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5347","article-title":"Cutting-edge LC-MS\/MS applications in clinical mass spectrometry: focusing on analysis of drugs and metabolites","volume":"36","author":"Maekawa","year":"2022","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125303_bb0185","article-title":"LC-MS\/MS-based multiplex antibacterial platform for therapeutic drug monitoring in intensive care unit patients","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jchromb.2026.125303_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/chromsci\/bmaf037","article-title":"Simultaneous measurement of mycophenolic acid with other immunosuppressants in whole blood and plasma by using liquid chromatography-tandem mass spectrometry","volume":"63","author":"Wang","year":"2025","journal-title":"J. Chromatogr. Sci."},{"issue":"Pt 1","key":"10.1016\/j.jchromb.2026.125303_bb0195","article-title":"Overview of therapeutic drug monitoring and clinical practice","volume":"266","author":"Fang","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2026.125303_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114964","article-title":"A UPLC-MS\/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM","volume":"220","author":"Qi","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125303_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1044234","article-title":"An LC-MS\/MS method for the simultaneous determination of 18 antibacterial drugs in human plasma and its application in therapeutic drug monitoring","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125303_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113273","article-title":"A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: application to critically ill pediatric patients","volume":"186","author":"Barco","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125303_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116489","article-title":"An LCMS\/MS method for the simultaneous determination of ten antimicrobials and its application in critically ill patients","volume":"252","author":"Liu","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125303_bb0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clinbiochem.2019.11.006","article-title":"An isotope dilution LC-MS\/MS based candidate reference method for the quantification of cyclosporine a, tacrolimus, sirolimus and everolimus in human whole blood","volume":"82","author":"Taibon","year":"2020","journal-title":"Clin. Biochem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:35:10Z","timestamp":1793352910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226003922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":44,"alternative-id":["S1570023226003922"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125303","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-throughput LC-MS\/MS assay for therapeutic drug monitoring of combined immunosuppressive and antimicrobial therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125303"}}